Ingevity Corporation (NYSE:NGVT – Get Free Report) CEO David Li sold 5,000 shares of the firm’s stock in a transaction on Friday, August 14th. The stock was sold at an average price of $75.73, for a total transaction of $378,650.00. Following the completion of the sale, the chief executive officer owned 125,636 shares in the company, valued at approximately $9,514,414.28. The trade was a 3.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ingevity Trading Down 2.3%
Shares of NGVT stock opened at $69.54 on Friday. Ingevity Corporation has a 1 year low of $45.85 and a 1 year high of $79.29. The firm’s fifty day simple moving average is $73.88 and its 200 day simple moving average is $71.84. The firm has a market capitalization of $2.39 billion, a P/E ratio of 47.31 and a beta of 1.16. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52.
Ingevity (NYSE:NGVT – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41. The firm had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, sell-side analysts predict that Ingevity Corporation will post 5.4 EPS for the current year.
Institutional Investors Weigh In On Ingevity
Analyst Upgrades and Downgrades
NGVT has been the subject of several research reports. Wall Street Zen cut shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a report on Friday, July 31st. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Ingevity currently has an average rating of “Hold” and a consensus target price of $80.00.
View Our Latest Stock Report on Ingevity
About Ingevity
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Read More
- Five stocks we like better than Ingevity
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
